The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Pancreatitis-Induced Inflammation Contributes to Pancreatic Cancer by Inhibiting Oncogene-Induced Senescence
Open accessAbstract
Pancreatic acinar cells of adult mice (≥P60) are resistant to transformation by some of the most robust oncogenic insults including expression of K-Ras oncogenes and loss of p16Ink4a/p19Arf or Trp53 tumor suppressors. Yet, these acinar cells yield pancreatic intraepithelial neoplasias (mPanIN) and ductal adenocarcinomas (mPDAC) if exposed to limited bouts of non-acute pancreatitis, providing they harbor K-Ras oncogenes. Pancreatitis contributes to tumor progression by abrogating the senescence barrier characteristic of low-grade mPanINs. Attenuation of pancreatitis-induced inflammation also accelerates tissue repair and thwarts mPanIN expansion. Patients with chronic pancreatitis display senescent PanINs, providing they have received antiinflammatory drugs. These results support the concept that antiinflammatory treatment of people diagnosed with pancreatitis may reduce their risk of developing PDAC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Tumor development in adult mice, however, can be greatly accelerated by chemically induced pancreatitis.”
From KRAS mutation in pancreatic cancer (2021) · cites this paper as [81]
In the citing paper
“Thus, inflammatory signaling is likely to play a critical role in pancreatic cancer development (80, 81).”
From KRAS mutation in pancreatic cancer (2021) · cites this paper as [81]
In the citing paper
“pancreatic acinar cells, in which Kras-G12V is activated during adulthood, exhibit a low frequency of PanIN development and resistance to transformation, at least in part due to OIS 118”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [118]
In the citing paper
“episodic pancreatitis induced by caerulein, a decapeptide analog of the gastrointestinal peptide hormone cholecystokinin, inhibited the OIS program, thus facilitating malignant transformation in this model 118”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [118]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Hidalgo, M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0901557 · Cited by 2,570
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
Pancreatitis and the Risk of Pancreatic Cancer
Lowenfels, A. B., Maisonneuve, P., Cavallini, G., Ammann, R., Lankisch, P. G., Andersen, J. R., DiMagno, E. P., Andrén‐Sandberg, Å., & Domellöf, L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282001 · Cited by 1,753
Rothwell, P. M., Fowkes, F. G. R., Belch, J. F., Ogawa, H., Warlow, C. P., & Meade, T. W. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62110-1 · Cited by 1,497
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482
Self-citationGuerra, C., Schuhmacher, A. J., Cañamero, M., Grippo, P. J., Verdaguer, L., Pérez-Gallego, L., Dubus, P., Sandgren, E. P., & Barbacid, M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.012 · Cited by 1,224
Self-citationSenescence in tumours: evidence from mice and humans
Collado, M., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2772 · Cited by 1,124 · cited 4×
“The Senescence Program Present in Low-Grade mPanIN Is Abrogated during Progression to High-Grade mPanIN Lesions Metaplasias and low-grade mPanINs observed in mice expressing K-RasG12V since embryonic development display senescence markers similar to those present in preneoplastic stages of other tumor types (Collado a…”
BackgroundInfluentialSelf-citation
Flagged first, then by citations
1 of the 40 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 523
Possible Involvement of Pancreatic Fatty Infiltration in Pancreatic Carcinogenesis
Hori, M., Mutoh, M., Imai, T., Nakagama, H., & Takahashi, M. (2016) · JOP, journal of the pancreas · Cited by 4
Cellular Plasticity and Heterogeneity in Pancreatic Regeneration and Malignancy
(2017) · Cancer Cell & Microenvironment · doi:10.14800/ccm.1472 · Cited by 4
Yazawa, K., Nakamura, F., Masukawa, D., Sato, S., Hiroshima, Y., Yabushita, Y., Mori, R., Matsuyama, R., Kato, I., Taniguchi, H., et al. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100746 · Cited by 4
Wang, H., Moniruzzaman, R., Li, L., Ji, B., Liu, Y., Zuo, X., Abbasgholizadeh, R., Zhao, J., Liu, G., Wang, R. L., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci163873 · Cited by 4
Grasso, D., Garcia, M. N., Hamidi, T., Cano, C. E., Calvo, E. L., Lomberk, G. A., Urrutia, R. A., & Iovanna, J. (2014) · Molecular & Cellular Oncology · doi:10.4161/mco.29913 · Cited by 4
Physiologie du pancréas exocrine
Dufresne, M. (2012) · EMC - Hépatologie · doi:10.1016/s1155-1976(12)59709-3 · Cited by 7
RETRACTED: GATA4 Regulates Inflammation-Driven Pancreatic Ductal Adenocarcinoma Progression
Jiang, W., Chen, C., Huang, L., Shen, J., & Yang, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.640391 · Cited by 4
RetractedPausch, T. M., Adolph, S., Felix, K., Bauer, A. S., Bergmann, F., Werner, J., & Hartwig, W. (2018) · Pancreas · doi:10.1097/mpa.0000000000001054 · Cited by 4
The Role of Tumor-Associated Macrophages (TAMs) in Tumor Progression
Schmieder, A., & Schledzewski, K. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1300-4_3 · Cited by 4
Narlik‐Grassow, M., Blanco‐Aparicio, C., Cecilia, Y., Perez, M., Muñoz-Galván, S., Marta, C., Renner, O., & Carnero, A. (2013) · PLoS ONE · doi:10.1371/annotation/1b8b6002-4e0f-4c5d-8ae8-fd45447b6149 · Cited by 4
Molecular dynamics driving phenotypic divergence among KRAS mutants in pancreatic tumorigenesis
Grimont, A., Falvo, D. J., Sisso, W. J., dos Santos, F., Chan, C. W., Zumbo, P., Fall, W. B., Ferrick, K. R., Pan, G., Cleveland, M., et al. (2026) · Developmental Cell · doi:10.1016/j.devcel.2026.06.016 · Cited by 4
Chemoprevention of Cancer: Past, Present, and Future
Sporn, M. B., & Liby, K. T. (2020) · Springer eBooks · doi:10.1007/978-3-030-39855-2_1 · Cited by 4
Jia, X., Sun, B., Tu, Q., Qi, H., Li, L., Liu, X., Yan, L., Dai, H., Kong, Q., Tang, C., et al. (2021) · Pancreatology · doi:10.1016/j.pan.2021.01.004 · Cited by 3
Premalignant lesions and cellular senescence
Georgakopoulou, E. A., Evangelou, K., & Gorgoulis, V. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00001-8 · Cited by 3
Silva‐Álvarez, S. D., & Collado, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.30066-9 · Cited by 4
Self-citationSilva‐Álvarez, S. D., & Collado, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00219-4 · Cited by 3
Self-citationLY6D identifies persistent stem-like cells driving pancreatic tumourigenesis
Shi, J., Wang, X., Tang, Y., Meng, S., Zhang, Z., Lu, P., Xu, J., Yu, F., Wang, X., Wang, Z., et al. (2026) · Gut · doi:10.1136/gutjnl-2025-336460 · Cited by 2
Advances in tuft cells, a chemosensory cell in sequential diseases of the pancreas
Wei, W., Zhang, W., Wu, S., Duan, W., & Wang, Z. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188911 · Cited by 2
Protein kinase D1 — A targetable mediator of pancreatic cancer development
Martinez, A. K. F., & Störz, P. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119646 · Cited by 2
Malignancies and IgG4‐related disease
Li, J., & Zhang, W. (2025) · Rheumatology & autoimmunity · doi:10.1002/rai2.12157 · Cited by 2
Nalbantoğlu, S., & Amri, H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817532-3.00006-2 · Cited by 2
Epigenetics in Health and Disease
Cabej, N. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814067-3.00014-4 · Cited by 2
Animal Modeling of Pancreatitis-to-Cancer Progression
Martinelli, P., & Real, F. X. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7193-0_66 · Cited by 2
Lundy, J., & Croagh, D. G. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3331-1_4 · Cited by 1
A Humanized Patient-Derived Xenograft Model for Pancreatic Cancer
Lundy, J. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3858-3_8 · Cited by 1
Diagnostic and Prognostic Markers for Pancreatitis and Pancreatic Ductal Adenocarcinoma
Kantheti, H. S., Hale, M. A., Choudhuri, S. P., Huang, H., Wang, X., Zolghadri, Y., Innamorati, G., Manikonda, S. P. R., Reddy, N. R., Reddy, S., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126619 · Cited by 1
Martinez, A. K. F., Döppler, H. R., Argo, R. A., Bastea, L. I., Edenfield, B. H., Espositio, I., & Störz, P. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02518-0 · Cited by 1
Spink1 promotes the survival of Kras-mutant pancreatic acinar cells
Hayashi, H., Hamada, S., Matsumoto, R., Takikawa, T., Xu, Y., Jie, R., Nakasuji, H., Abe, T., Kikuta, K., Motohashi, H., et al. (2026) · Pancreatology · doi:10.1016/j.pan.2026.03.014 · Cited by 1
Dissecting histological transformation
Earlie, E. M., Gardner, E. E., VARMUS, H. E., & Laughney, A. M. (2026) · Trends in cancer · doi:10.1016/j.trecan.2026.02.001 · Cited by 1
Regulatory elements in the Sox9 locus license the initiation of pancreatic ductal adenocarcinoma
Ballester, M., Kurilla, A., Dai, Y., Bergara-Muguruza, L., Radke, K., Maurer, H. C., Espinet, E., Høj, K., Marisch-Delgado, A., Seymour, P. A., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117176 · Cited by 2
Improving the Outcomes: Developing Cancer Therapeutics
Utku, N. (2011) · Future Oncology · doi:10.2217/fon.11.136 · Cited by 1
Risk Factors for Pancreatic Cancer: Underlying Mechanisms and Potential Targets
(2015) · Frontiers research topics · doi:10.3389/978-2-88919-468-1 · Cited by 1
RalGAP complexes control secretion and primary cilia in pancreatic disease
Apken, L. H., Barz, H., Beel, S., Michalke, E., Rasche, R., Verma, A., Ricker, A., Nüsse, H., Klingauf, J., Kerl, K., et al. (2025) · Life Science Alliance · doi:10.26508/lsa.202403123 · Cited by 1
Pancreatic cancer vaccine: a unique potential therapy
Novelli, F., Principe, M., & Cappello, P. (2015) · Gastrointestinal Cancer Targets and Therapy · doi:10.2147/gictt.s55850 · Cited by 1
Animal Modeling of Pancreatitis-to-Cancer Progression
Martinelli, P., & Real, F. X. (2017) · Springer eBooks · doi:10.1007/978-1-4939-6631-8_66-1 · Cited by 1
Wu, Y., Konaté, M. M., Hollingshead, M. G., Karim, B. O., Diebold, B. A., Lu, J., Antony, S., Meitzler, J. L., Juhasz, A. N., Jiang, G., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.13.480277 · Cited by 1
From Tissue Turnover to the Cell of Origin of Pancreatic Cancer
Kong, B., Thoma, E., & Michalski, C. W. (2023) · doi:10.1002/9781119876007.ch120 · Cited by 1
Fantuz, M., Liebig, J., Fontana, G., Iebba, V., Carbone, C., Lukassen, S., Conrad, C., & Carrer, A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.04.600210 · Cited by 1
Pancreatic Inflammation and Carcinogenesis
Miller, C. P. Z. A. G. (2015) · doi:10.3998/panc.2015.6 · Cited by 1
Galván-del-Rey, A., López-Gil, J. C., Archibugi, L., Alcalá, S., Earl, J., Bevere, M., Agostini, A., Noguera‐Castells, A., Parejo-Alonso, B., Royo-García, A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.10.703309 · Cited by 1
Self-citationActive, Dormant, or on the Path to Elimination: What Does a Senescent Cell Do?
Ben‐Porath, I. (2014) · Springer eBooks · doi:10.1007/978-94-017-9325-4_1
The Biology of K-Ras Signaling Pathways in Pancreatic Cancer
Court, H., Philips, M. R., & Bar‐Sagi, D. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6549-2_5
Chronic Pancreatitis as an Inductor of Pancreatic Cancer — Correlations With Inflammatory Pathways
Dima, S., Cucu, D., Bacalbas, N., & Popescu, I. (2015) · InTech eBooks · doi:10.5772/59714
Stem Cells and Pancreatic Cancer
Garcı́a-Silva, S., & Heeschen, C. (2014) · doi:10.1002/9781118356203.ch16
The Molecular Frame of Pancreatic Carcinogenesis
Heßmann, E., Baumgart, S., Chen, N., Singh, S. K., Singh, G., König, A., Neeße, A., & Ellenrieder, V. (2014) · InTech eBooks · doi:10.5772/57422
Neuroplastic changes in a mouse model of pancreatic ductal adenocarcinoma
Stopczynski, R. E. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
Ikehara, Y. (2014) · Springer eBooks · doi:10.1007/978-4-431-54836-2_194-2
Energy balance modulation and pancreatic tumor growth : the role of NF-kB
Hays, D. (2012) · Texas ScholarWorks (Texas Digital Library)
Deepak, R., Khoshchehreh, R., Aicher, A., & Heeschen, C. (2015) · Springer eBooks · doi:10.1007/978-3-319-21030-8_10
Analysis of Transplanted Bone Marrow-Derived Cells in Chronic Pancreatitis
Westphalen, C. B., Marrache, F., & Wang, T. C. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-287-2_16
Genetic Susceptibility and Risk of Pancreatic Cancer
Hoskins, J. W., Jia, J., & Amundadottir, L. T. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-408103-1.00008-x · Cited by 1
Cross Talk Between Snail and Mutant K-Ras Contributes to Pancreatic Cancer Progression
Chow, C. R., Ebine, K., Hattaway, H. Z., Kumar, K., & Munshi, H. G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803505-4.00007-2
賢一, 佐. (2013) · 日本消化機病學會雜誌. 乙 · doi:10.11405/nisshoshi.110.2042
Signaling and Chromatin Networks in Cancer Biology
Heßmann, E., Urrutia, R. A., & König, A. O. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802389-1.00013-7
Oncogenic KRAS and the Inflammatory Micro-Environment in Pancreatic Cancer
Chang, H.-H., Schmidt, A., & Eibl, G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803505-4.00005-9
Disruptive chemicals, senescence and immortality
Almagro, F., & Kyoto, S.-K. (2015)
L’inflammation générée par les pancréatites contribue à la formation d’adénocarcinomes pancréatiques
Larsen, C. (2011) · Bulletin du Cancer · doi:10.1684/bdc.2011.1460
Lin, B. (2017) · OpenCommons at University of Connecticut (University of Connecticut)
Elucidating the role of SMAD7 in pancreatic cancer through in vivo studies
Savant, S. S. (2017) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1806
Caracterização de alvos moleculares em tumores associados ao Papilomavírus Humano
Silveira, C. R. F. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2019.tde-11062019-111716
Rangelova, E. B. (2019) · Figshare
Role of stromal SPARC in PDAC tumorigenesis and drug delivery
Ramu, I. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7723
Combating pancreatic cancer during its Rip Van Winkle sleep
Görgülü, K., Lesina, M., & Algül, H. (2020) · Cell Research · doi:10.1038/s41422-020-0348-z
MicroRNAs as bile-based biomarkers for pancreatic and biliary-tract cancers
Prado, M. M. (2018) · Spiral (Imperial College London) · doi:10.25560/81592
A Case of Ectopic Pancreatic Cancer in the Stomach after Recurrent Phlegmonous Gastritis
Nagano, T., Sadanaga, N., Yoshida, R., Motomura, T., Honbou, T., & Matsuura, H. (2020) · Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) · doi:10.3919/jjsa.81.866
Tracing tumor evolution and subtype specification in pancreatic cancerPreprint
Rajbhandari, N., Hamilton, M., Quintero, C. M., Ferguson, L. P., Fox, R., Schürch, C. M., Wang, J., Nakamura, M., McDermott, M. L., Pettit, H. W., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-101578/v1
Cancer Microenvironments as Therapeutic Targets
Kumar, S., & Coussens, L. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.01909-2
Occurrence of Malignant Neoplasms
Shimizu, K. (2014) · Springer eBooks · doi:10.1007/978-3-642-55086-7_26
Offringa, R. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717956882.793461428
Ikehara, Y. (2014) · Springer eBooks · doi:10.1007/978-4-431-54841-6_194
Ikehara, Y., Yamaguchi, T., & Ikehara, S. K. (2014) · Springer eBooks · doi:10.1007/978-4-431-54836-2_194-1
Faculty Opinions recommendation of Cell of origin influences pancreatic cancer subtype.
Sosa‐Pineda, B. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.739647870.793585324
Sosa‐Pineda, B., & Martínez-Ramírez, A. S. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737383506.793574902
Brunet, M., Vargas, C., Fanjul, M., Pieruccioni, L., Varry, D., Labrousse, G., Lulka, H., Capilla, F., Couvelard, A., Gigoux, V., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.08.531649
Urosevic, J., Blasco, M. T., Lope, A. L., Bellmunt, A., Berenguer, A., Guiu, M., Cañellas-Socias, A., Fernández, E., Burkov, I., Clapés, M., et al. (2023) · doi:10.1158/0008-5472.c.6512596.v1
Zhao, Y., Wu, Z., Chanal, M., Guillaumond, F., Goehrig, D., Bachy, S., Principe, M., Ziverec, A., Flaman, J., Collin, G., et al. (2023) · doi:10.1158/0008-5472.c.6511539.v1
Data from Metabolic Regulator IAPP (Amylin) Is Required for BRAF and RAS Oncogene-Induced Senescence
Garnett, S., de Bruyns, A., Provencher-Tom, V., Dutchak, K., Shu, R., & Dankort, D. L. (2023) · doi:10.1158/1541-7786.c.6545253
Data from Cell of Origin Influences Pancreatic Cancer Subtype
Flowers, B. M., Xu, H., Mulligan, A. S., Hanson, K. J., Seoane, J. A., Vogel, H. S., Curtis, C. N., Wood, L. D., & Attardi, L. D. (2023) · doi:10.1158/2159-8290.c.6547895.v1
Data from MOB3A Bypasses BRAF and RAS Oncogene-Induced Senescence by Engaging the Hippo Pathway
Dutchak, K., Garnett, S., Nicoll, M., de Bruyns, A., & Dankort, D. L. (2023) · doi:10.1158/1541-7786.c.6545418.v1
Data from Metabolic Regulator IAPP (Amylin) Is Required for BRAF and RAS Oncogene-Induced Senescence
Garnett, S., de Bruyns, A., Provencher-Tom, V., Dutchak, K., Shu, R., & Dankort, D. L. (2023) · doi:10.1158/1541-7786.c.6545253.v1
Alsiary, R., Katouah, H. A., Al-Amodi, H. S. A. B., & Al-Toub, M. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815080384123010007
Söderqvist, S., Viljamaa, A., Geyer, N., Strell, C., Hekmati, N., Engstrand, J., Sparrelid, E., Salmén, C., Heuchel, R. L., Zacharouli, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.14.584614
Additional file 3 of The EGFR-HSF1 axis accelerates the tumorigenesis of pancreatic cancer
Qian, W., Chen, K., Qin, T., Xiao, Y., Li, J., Yue, Y., Zhou, C., Ma, J., Duan, W., Lei, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13551075
Additional file 4 of The EGFR-HSF1 axis accelerates the tumorigenesis of pancreatic cancer
Qian, W., Chen, K., Qin, T., Xiao, Y., Li, J., Yue, Y., Zhou, C., Ma, J., Duan, W., Lei, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13551078
Additional file 2 of The EGFR-HSF1 axis accelerates the tumorigenesis of pancreatic cancer
Qian, W., Chen, K., Qin, T., Xiao, Y., Li, J., Yue, Y., Zhou, C., Ma, J., Duan, W., Lei, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13551072
Zhang, X., Chen, Z., Zhao, X. H., Pan, J., Pandol, S. J., & Li, W. (2024) · Journal of Pancreatology · doi:10.1097/jp9.0000000000000188
Jacquemin, P. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.101394
KRAS-driven cancer models for in vivo pharmacology and drug discovery
Chugh, S., Dow, L. E., Singh, M., & Aguirre, A. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21861-3.00004-8
Zoi, I., Rajput, M., Holguín-Horcajo, A., Haidar, M., Brusa, D., Chu, K., Xie, J., Shields, M. A., Ferreira, S., Stanger, B. Z., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.07.642043
Ballester, M., Kurilla, A., Dai, Y., Maurer, H. C., Espinet, E., Høj, K., Delgado, A. M., Seymour, P. A., Omar, S., Rift, C. V., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.06.658264
Kumar, S., Chan, C. J., Coussens, L. M., Whiteside, S. K., & Roychoudhuri, R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00164-2
Mevalonate Biosynthesis is a Metabolic Vulnerability of Gemcitabine-resistant Pancreatic CancerPreprint
Beutel, A. K., Calderon, S. E., Nghiem, E., Gulay, K. C. M., Santana, L. P. S., Zimmer, E., Singh, R., Anaraki, C., Yousefian, N., Allgöwer, C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.19.675739
Targeting cellular senescence for cancer therapy
Abduljabbar, R., Liu, Y., Mussa, A., Abdu, A. M. A., Man, Y., Chen, Q., & Liu, Z. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126297
ADAM17-dependent Autocrine and Paracrine Signaling Promotes Pancreatic Premalignant Progression
Wen, H.-J., Davis, E. T., Moore, J. S., Brender, S. M., Benitz, S., Wombwell, A. M., Loveless, I. M., Long, D. W., Salas-Escabillas, D. J., Lee, J., et al. (2025) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2025.101711
Okabe, J., Kodama, T., Sato, Y., Shigeno, S., Matsumae, T., Daiku, K., Sato, K., Yoshioka, T., Shigekawa, M., Higashiguchi, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24277240
Additional file 1 of The EGFR-HSF1 axis accelerates the tumorigenesis of pancreatic cancer
Qian, W., Chen, K., Qin, T., Xiao, Y., Li, J., Yue, Y., Zhou, C., Ma, J., Duan, W., Lei, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13551069
Fan, Y.-C., Fong, Y.-C., Kuo, C.-T., Li, C.-W., Chen, W.-Y., Lin, J.-D., Bürtin, F., Linnebacher, M., Bui, Q. T., Lee, K.-D., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23930443
Okabe, J., Kodama, T., Sato, Y., Shigeno, S., Matsumae, T., Daiku, K., Sato, K., Yoshioka, T., Shigekawa, M., Higashiguchi, M., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24277137
Chronic pancreatitis and pancreatic cancer: It is in the genes!
Jain, K., & Midha, S. (2026) · Pancreatology · doi:10.1016/j.pan.2026.01.002
Metadata
- Authors
- Guerra, C., Collado, M., Navas, C., Schuhmacher, A. J., Hernández-Porras, I., Cañamero, M., Rodriguez-Justo, M., Serrano, M., & Barbacid, M.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Corresponding author
- Guerra, Carmen
- Barbacid, Mariano
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2011-06
- Volume
- 19
- Issue
- 6
- Pages
- 728-739
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC4890723
- OpenAlex
- W1965887568
- Cited by
- 516
- References
- 40
- Citations by year
- 2026: 17 · 2025: 20 · 2024: 31 · 2023: 40 · 2022: 22 · 2021: 44 · 2020: 36 · 2019: 41 · 2018: 27 · 2017: 36 · 2016: 22 · 2015: 37 · 2014: 65 · 2013: 38 · 2012: 33
- FWCI
- 22.55
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 813 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- European Research Council (ERC-AG/250297-RAS AHEAD)
- Ministerio de Ciencia e Innovación (CSD2007-00017, SAF2006-11773)
- INCLIVA Instituto de Investigación Sanitaria (ERC-AG/233270, GR/SAL/0349/2004, PI042124, SAF2008-02959)
- Fundación Mutua Madrileña
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- pancreatitis, pancreatic cancer, oncogene-induced senescence, inflammation, pancreatic intraepithelial neoplasia, K-ras oncogene, chronic pancreatitis, anti-inflammatory agents, tissue repair, tumor progression, p16INK4a, Trp53, pancreatic ductal adenocarcinoma
- MeSH terms
- Adenocarcinoma, Animals, Anti-Inflammatory Agents, Cell Transformation, Neoplastic, Humans, Pancreatic Neoplasms, Pancreatitis, Genes, ras, Genes, p53, Cellular Senescence, Cyclin-Dependent Kinase Inhibitor p16, Carcinoma, Pancreatic Ductal, Pancreas, Exocrine, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review